Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma
Condition:   Head and Neck Cancer Intervention:   Drug: Anti-EGFR monoclonal antibody Sponsors:   Sinocelltech Ltd.;   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled Trial
Conditions:   Breast Cancer;   Acute Pain;   Anesthesia Interventions:   Procedure: PVB group;   Procedure: MTP block group;   Procedure: Control Group Sponsor:   Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

SeVIHanal Real-life Cohort of HIV-infected Patients at High or Low Risk for Anal Cancer
Condition:   Anal Squamous Intraepithelial Neoplasia Intervention:   Diagnostic Test: Screening for anal squamous intraepithelial lesions Sponsor:   Hospitales Universitarios Virgen del Rocío Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

NEUWAVE Flexible Probe Study #2
Conditions:   Cancer of the Lung;   Lung Cancer;   Neoplasms, Lung;   Carcinoma, Non-Small Cell Lung;   Non-Small Cell Lung Cancer;   Non-Small Cell Lung Carcinoma Intervention:   Device: Microwave ablation Sponsor:   Ethicon, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers
Condition:   Oropharyngeal Cancer Intervention:   Device: TraceIT Tissue Marker Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

CAELYX ® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER
Condition:   Breast Cancer Intervention:   Drug: Caelyx® Sponsors:   European Institute of Oncology;   Janssen-Cilag International NV Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
Conditions:   Colorectal Cancer;   Metastatic Colorectal Cancer;   Colon Cancer Interventions:   Drug: Regorafenib;   Drug: Nivolumab Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency
Condition:   Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Homologous Recombination Deficiency (HRD) Intervention:   Drug: Pamiparib 60 mg PO BID Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma
Condition:   Uveal Melanoma Interventions:   Radiation: Stereotactic Body Radiation Therapy;   Biological: Ziv-Aflibercept Sponsors:   Sidney Kimmel Cancer Center at Thomas Jefferson University;   Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies
Condition:   Hematopoietic and Lymphoid Cell Neoplasm Interventions:   Radiation: Total-Body Irradiation;   Procedure: Donor Lymphocyte Infusion;   Drug: Cyclophosphamide;   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Tacrolimus;   Drug: Mycophenolate Mofetil Sponsor:   Sidney Kimmel Cancer Center at Thomas Jefferson University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors
Condition:   Breast Cancer Intervention:   Device: Macrodyne LivMD plate Sponsor:   Indiana University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer
Conditions:   Quality of Life;   Chemoradiation;   Esophageal Cancer Interventions:   Other: EORTC QLQ C30;   Other: EORTC QLQ OES-18;   Other: EORTC OG-25 Sponsor:   Ludwig-Maximilians - University of Munich Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Efficacy and Safety of DIGNICAP ™ System
Conditions:   Breast Cancer;   Chemotherapy-induced Alopecia Intervention:   Device: DIGNICAP™ Sponsor:   European Institute of Oncology Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer
Conditions:   Pathologic Stage I Merkel Cell Carcinoma AJCC v8;   Pathologic Stage II Merkel Cell Carcinoma AJCC v8;   Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8;   Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8;   Pathologic Stage III Merkel Cell Carcinoma AJCC v8;   Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8;   Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8;   Resected Mass Interventions:   Other: Best Practice;   Biological: Pembrolizumab;   Radiation:...
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
Conditions:   Cancer;   Esophagus Squamous Cell Carcinoma;   Squamous Cell Carcinoma of the Head and Neck;   Anal Canal Squamous Cell Carcinoma;   Metastatic Cancer Intervention:   Sponsor:   University Health Network, Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Examining Early Palliative Care in Newly Diagnosed Cancer Patients
Condition:   Cancer Interventions:   Combination Product: Palliative care;   Combination Product: Standard oncological care Sponsor:   Yale University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy
Condition:   Head & Neck Cancer Intervention:   Drug: nanoliposomal irinotecan Sponsors:   National Health Research Institutes, Taiwan;   China Medical University Hospital;   Tri-Service General Hospital;   Taipei Veterans General Hospital, Taiwan;   National Cheng-Kung University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Study of Chitosan for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients
Condition:   Prostate Cancer Intervention:   Drug: Chitosan Sponsor:   Medical University of South Carolina Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Descriptive Observational Study of the Evolution of the Lifestyle Alteration in Patients With Breast Cancer
Condition:   Breast Cancer Intervention:   Behavioral: Lifestyle alteration Sponsor:   Hospices Civils de Lyon Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Post-Operative Outcomes of Low Thermal Dissection vs. Traditional Electrosurgery
Conditions:   Breast Cancer;   Mastectomy;   Perfusion; Complications;   Hemostasis Intervention:   Device: PlasmaBlade 3.0S Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   Medtronic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer
Conditions:   Pancreatic Carcinoma;   Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type Interventions:   Procedure: Optical Coherence Tomography;   Procedure: Therapeutic Conventional Surgery;   Diagnostic Test: Laboratory Evaluation Sponsors:   Ohio State University Comprehensive Cancer Center;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Comparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Condition:   Primary Breast Cancer Interventions:   Device: Scalp cooling system;   Device: Cold cap Sponsor:   Tao OUYANG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Safety and Efficacy of SCT200 in Head and Neck Squamous Cell Carcinoma
Condition:   Head and Neck Cancer Intervention:   Drug: Anti-EGFR monoclonal antibody Sponsors:   Sinocelltech Ltd.;   Cancer Institute and Hospital, Chinese Academy of Medical Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Mid-point Transverse Process to Pleura Block for Breast Cancer Surgery: A Randomized Controlled Trial
Conditions:   Breast Cancer;   Acute Pain;   Anesthesia Interventions:   Procedure: PVB group;   Procedure: MTP block group;   Procedure: Control Group Sponsor:   Ottawa Hospital Research Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

SeVIHanal Real-life Cohort of HIV-infected Patients at High or Low Risk for Anal Cancer
Condition:   Anal Squamous Intraepithelial Neoplasia Intervention:   Diagnostic Test: Screening for anal squamous intraepithelial lesions Sponsor:   Hospitales Universitarios Virgen del Rocío Enrolling by invitation (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

NEUWAVE Flexible Probe Study #2
Conditions:   Cancer of the Lung;   Lung Cancer;   Neoplasms, Lung;   Carcinoma, Non-Small Cell Lung;   Non-Small Cell Lung Cancer;   Non-Small Cell Lung Carcinoma Intervention:   Device: Microwave ablation Sponsor:   Ethicon, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

TraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers
Condition:   Oropharyngeal Cancer Intervention:   Device: TraceIT Tissue Marker Sponsor:   Washington University School of Medicine Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

CAELYX ® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER
Condition:   Breast Cancer Intervention:   Drug: Caelyx® Sponsors:   European Institute of Oncology;   Janssen-Cilag International NV Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Regorafenib and Nivolumab in Mismatch Repair (MMR) Refractory Colorectal Cancer
Conditions:   Colorectal Cancer;   Metastatic Colorectal Cancer;   Colon Cancer Interventions:   Drug: Regorafenib;   Drug: Nivolumab Sponsors:   H. Lee Moffitt Cancer Center and Research Institute;   Bristol-Myers Squibb Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer With Homologous Recombination Deficiency
Condition:   Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Homologous Recombination Deficiency (HRD) Intervention:   Drug: Pamiparib 60 mg PO BID Sponsor:   BeiGene Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma
Condition:   Uveal Melanoma Interventions:   Radiation: Stereotactic Body Radiation Therapy;   Biological: Ziv-Aflibercept Sponsors:   Sidney Kimmel Cancer Center at Thomas Jefferson University;   Regeneron Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies
Condition:   Hematopoietic and Lymphoid Cell Neoplasm Interventions:   Radiation: Total-Body Irradiation;   Procedure: Donor Lymphocyte Infusion;   Drug: Cyclophosphamide;   Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Tacrolimus;   Drug: Mycophenolate Mofetil Sponsor:   Sidney Kimmel Cancer Center at Thomas Jefferson University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Effect of Low Intensity Vibration (LIV) on Aromatase Inhibitor- Induced Musculoskeletal Dysfunction in Early Stage Breast Cancer Survivors
Condition:   Breast Cancer Intervention:   Device: Macrodyne LivMD plate Sponsor:   Indiana University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Prospective Observational Trial to Evaluate Quality of Life After Neoadjuvant or Definitive Chemoradiation in Patients With Esophageal Cancer
Conditions:   Quality of Life;   Chemoradiation;   Esophageal Cancer Interventions:   Other: EORTC QLQ C30;   Other: EORTC QLQ OES-18;   Other: EORTC OG-25 Sponsor:   Ludwig-Maximilians - University of Munich Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Efficacy and Safety of DIGNICAP ™ System
Conditions:   Breast Cancer;   Chemotherapy-induced Alopecia Intervention:   Device: DIGNICAP™ Sponsor:   European Institute of Oncology Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer
Conditions:   Pathologic Stage I Merkel Cell Carcinoma AJCC v8;   Pathologic Stage II Merkel Cell Carcinoma AJCC v8;   Pathologic Stage IIA Merkel Cell Carcinoma AJCC v8;   Pathologic Stage IIB Merkel Cell Carcinoma AJCC v8;   Pathologic Stage III Merkel Cell Carcinoma AJCC v8;   Pathologic Stage IIIA Merkel Cell Carcinoma AJCC v8;   Pathologic Stage IIIB Merkel Cell Carcinoma AJCC v8;   Resected Mass Interventions:   Other: Best Practice;   Biological: Pembrolizumab;   Radiation:...
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy
Conditions:   Cancer;   Esophagus Squamous Cell Carcinoma;   Squamous Cell Carcinoma of the Head and Neck;   Anal Canal Squamous Cell Carcinoma;   Metastatic Cancer Intervention:   Sponsor:   University Health Network, Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Examining Early Palliative Care in Newly Diagnosed Cancer Patients
Condition:   Cancer Interventions:   Combination Product: Palliative care;   Combination Product: Standard oncological care Sponsor:   Yale University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Nanoliposomal Irinotecan in Head & Neck and Esophagus After Prior Platinum-based Chemotherapy or Chemoradiotherapy
Condition:   Head & Neck Cancer Intervention:   Drug: nanoliposomal irinotecan Sponsors:   National Health Research Institutes, Taiwan;   China Medical University Hospital;   Tri-Service General Hospital;   Taipei Veterans General Hospital, Taiwan;   National Cheng-Kung University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Study of Chitosan for Pharmacologic Manipulation of AGE (Advanced Glycation Endproducts) Levels in Prostate Cancer Patients
Condition:   Prostate Cancer Intervention:   Drug: Chitosan Sponsor:   Medical University of South Carolina Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Descriptive Observational Study of the Evolution of the Lifestyle Alteration in Patients With Breast Cancer
Condition:   Breast Cancer Intervention:   Behavioral: Lifestyle alteration Sponsor:   Hospices Civils de Lyon Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Post-Operative Outcomes of Low Thermal Dissection vs. Traditional Electrosurgery
Conditions:   Breast Cancer;   Mastectomy;   Perfusion; Complications;   Hemostasis Intervention:   Device: PlasmaBlade 3.0S Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   Medtronic Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Ultra-High Resolution Optical Coherence Tomography in Detecting Micrometer Sized Early Stage Pancreatic Cancer in Participants With Pancreatic Cancer
Conditions:   Pancreatic Carcinoma;   Pancreatic Intraductal Papillary Mucinous Neoplasm, Pancreatobiliary-Type Interventions:   Procedure: Optical Coherence Tomography;   Procedure: Therapeutic Conventional Surgery;   Diagnostic Test: Laboratory Evaluation Sponsors:   Ohio State University Comprehensive Cancer Center;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Comparative Study of Scalp Cooling System and Chemical Cold Cap (COHAIR Study)
Condition:   Primary Breast Cancer Interventions:   Device: Scalp cooling system;   Device: Cold cap Sponsor:   Tao OUYANG Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2018 Category: Research Source Type: clinical trials

Afatinib on CNS Metastases and LMD in EGFR Mutation Positive NSCLC
Conditions:   Non-small Cell Lung Cancer;   Leptomeningeal Disease;   Central Nervous System Metastases Intervention:   Drug: Afatinib Sponsor:   National Cancer Centre, Singapore Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2018 Category: Research Source Type: clinical trials

The Efficacy of Bevacizumab Combined With m-FOLFOXIRI in Borderline Resectable Colorectal Liver Metastases
Condition:   Colorectal Cancer Interventions:   Drug: bevacizumab;   Drug: Oxaliplatin;   Drug: Irinotecan;   Drug: Leucovorin;   Drug: 5-FU Sponsor:   National Cheng-Kung University Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2018 Category: Research Source Type: clinical trials

Study of Carboplatin Plus Etoposide With or Without SHR-1316 in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
Condition:   Extensive-stage Small Cell Lung Cancer Interventions:   Drug: SHR-1316;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Placebo Sponsor:   Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2018 Category: Research Source Type: clinical trials

Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
Conditions:   Unresectable or Metastatic Microsatellite Stable (MSS) Solid Tumor Along With Microsatellite Stable (MSS) Colon Cancer;   Colon Cancer Interventions:   Drug: Copanlisib;   Drug: Nivolumab Sponsors:   Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins;   Bayer;   Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2018 Category: Research Source Type: clinical trials

Cardiovascular Prevention Strategies in Elderly Patients With Cancer (CARTIER Clinical Trial)
Conditions:   Cancer (Colon Cancer, Breast Cancer, Lymphoma, Multiple Myeloma);   Elderly;   Antineoplastic Agents;   Cardiotoxicity Interventions:   Other: Intensive cardiovascular monitoring;   Other: No intervention Sponsors:   Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León;   IBSAL-Instituto de Investigación Biomédica de Salamanca, Fundación IECSCYL-IBSAL;   Instituto de Salud Carlos III Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2018 Category: Research Source Type: clinical trials

Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Bacillus Calmette-Guerin (BCG) in High-Risk Non-Muscle Invasive Bladder Cancer (HR NMIBC) (MK-3475-676/KEYNOTE-676)
Condition:   High-risk Non-muscle Invasive Bladder Cancer Interventions:   Biological: Pembrolizumab;   Biological: BCG Sponsor:   Merck Sharp & Dohme Corp. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2018 Category: Research Source Type: clinical trials